Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wichai Chinratanalab

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Cancer Research|July 19, 2002
Herceptin-induced inhibition of phosphatidylinositol-3 kinase and Akt Is required for antibody-mediated effects on p27, cyclin D1, and antitumor actionF Michael Yakes, Wichai Chinratanalab, Christoph A Ritter, et al.
Clinical Hematology International|October 1, 2021
Use of Biosimilar Granulocyte Colony-Stimulating Factor for Mobilization in Autologous and Allogeneic Hematopoietic Stem Cell TransplantationDwight D Eplin, Anna D Jackson, Austin M Smith, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 21, 2003
Gastrointestinal involvement in chronic graft-versus-host disease: a clinicopathologic studyGörgün Akpek, Wichai Chinratanalab, Linda A Lee, et al.
Clinical Hematology International|July 29, 2024
SARS-CoV2 is not just infection but a culprit of donor graft failure post-allogeneic stem cell transplantYoojin Park, Silvia Park, Wichai Chinratanalab, et al.
Blood|June 13, 2009
Does peritransplantation use of rituximab reduce the risk of EBV reactivation and PTLPD?Bipin N Savani, Paula R Pohlmann, Madan Jagasia, et al.
Experimental Hematology|January 25, 2012
Immunomodulatory nonablative conditioning regimen for B-cell lymphoid malignanciesWichai Chinratanalab, Nishitha Reddy, John P Greer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 6, 2016
Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and Rituximab Is Associated with Improved Outcomes Compared with Fludarabine and Busulfan after Allogeneic Stem Cell Transplantation for B Cell MalignanciesVanessa E Kennedy, Bipin N Savani, John P Greer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 3, 2017
Optimizing Antithymocyte Globulin Dosing for Unrelated Donor Allogeneic Hematopoietic Cell Transplantation Based on Recipient Absolute Lymphocyte CountVanessa E Kennedy, Heidi Chen, Bipin N Savani, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 15, 2009
Classic and overlap chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP)Madan H Jagasia, Bipin N Savani, George Stricklin, et al.
Experimental Hematology|January 25, 2012
Consolidative therapy with stem cell transplantation improves survival of patients with mantle cell lymphoma after any induction regimenNishitha Reddy, John P Greer, Stacey Goodman, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Cancer Research|July 19, 2002
Herceptin-induced inhibition of phosphatidylinositol-3 kinase and Akt Is required for antibody-mediated effects on p27, cyclin D1, and antitumor actionF Michael Yakes, Wichai Chinratanalab, Christoph A Ritter, et al.
Clinical Hematology International|October 1, 2021
Use of Biosimilar Granulocyte Colony-Stimulating Factor for Mobilization in Autologous and Allogeneic Hematopoietic Stem Cell TransplantationDwight D Eplin, Anna D Jackson, Austin M Smith, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 21, 2003
Gastrointestinal involvement in chronic graft-versus-host disease: a clinicopathologic studyGörgün Akpek, Wichai Chinratanalab, Linda A Lee, et al.
Clinical Hematology International|July 29, 2024
SARS-CoV2 is not just infection but a culprit of donor graft failure post-allogeneic stem cell transplantYoojin Park, Silvia Park, Wichai Chinratanalab, et al.
Blood|June 13, 2009
Does peritransplantation use of rituximab reduce the risk of EBV reactivation and PTLPD?Bipin N Savani, Paula R Pohlmann, Madan Jagasia, et al.
Experimental Hematology|January 25, 2012
Immunomodulatory nonablative conditioning regimen for B-cell lymphoid malignanciesWichai Chinratanalab, Nishitha Reddy, John P Greer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 6, 2016
Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and Rituximab Is Associated with Improved Outcomes Compared with Fludarabine and Busulfan after Allogeneic Stem Cell Transplantation for B Cell MalignanciesVanessa E Kennedy, Bipin N Savani, John P Greer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 3, 2017
Optimizing Antithymocyte Globulin Dosing for Unrelated Donor Allogeneic Hematopoietic Cell Transplantation Based on Recipient Absolute Lymphocyte CountVanessa E Kennedy, Heidi Chen, Bipin N Savani, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 15, 2009
Classic and overlap chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP)Madan H Jagasia, Bipin N Savani, George Stricklin, et al.
Experimental Hematology|January 25, 2012
Consolidative therapy with stem cell transplantation improves survival of patients with mantle cell lymphoma after any induction regimenNishitha Reddy, John P Greer, Stacey Goodman, et al.
Pageof 4